Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrew Krueger
Observed names:
Andrew S Krueger,
Andrew S. Krueger
Institution:
Takeda Oncology (United States)
Observed institutions:
Boston University,
Takeda Oncology (United States)
OpenAlex ID:
A5073767910
Synergistic drug combinations tend to improve therapeutically relevant selectivity
2009
·
Joseph Lehár
, Andrew S Krueger
, et al.
·
Nature Biotechnology
·
941
The Mycobacterium tuberculosis regulatory network and hypoxia
2013
·
James E. Galagan
, Kyle Minch
, et al.
·
Nature
·
431
PDF
Chemical combination effects predict connectivity in biological systems
2007
·
Joseph Lehár
, Grant R Zimmermann
, et al.
·
Molecular Systems Biology
·
275
PDF
Sequence-Dependent Basepair Opening in DNA Double Helix
2006
·
Andrew Krueger
, Ekaterina Protozanova
, et al.
·
Biophysical Journal
·
166
High‐order combination effects and biological robustness
2008
·
Joseph Lehár
, Andrew Krueger
, et al.
·
Molecular Systems Biology
·
95
PDF
Therapeutic selectivity and the multi-node drug target.
2009
·
Joseph Lehar
, Andrew S Krueger
, et al.
·
PubMed
·
23
Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity
2009
·
Joseph Lehár
, Andrew S Krueger
, et al.
·
Nature Biotechnology
·
21
PDF
Simulating Serial-Target Antibacterial Drug Synergies Using Flux Balance Analysis
2016
·
Andrew S. Krueger
, Christian Munck
, et al.
·
PLoS ONE
·
20
PDF
Abstract 5549: Novel network predictor for drug sensitivity in cell line response data
2017
·
Ana Brandusa Pavel
, Bin Li
, et al.
·
Cancer Research
Abstract B1-59: Identification of key molecular characteristics for achieving increased anti-tumor activity by combined mTORC1/2 and MEK1/2 investigational agents
2015
·
Hyunjin Shin
, Andrew Krueger
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
1,972
H-index:
8
I10-index:
8
Year
Topic
Type
